Press ReleasesJune 3, 2019Neurosurgery Medical Device Maker, NICO Corporation, Expands Globally with International Training Course During World Stroke Meeting in SpainApril 23, 2019New Evidence Shows Brain Recovery after Traumatic & Spontaneous Intracerebral Hemorrhage using NICO Minimally Invasive BrainPath ApproachNovember 19, 2018NICO Completes $12.5 Million Capital Raise Supported by Current ShareholdersNovember 14, 2018NICO Awards First Investigator Initiated Study Grant to Mayo ClinicNovember 14, 2018Viz.ai and NICO Announce Collaboration to Speed Patient Recruitment in the ENRICH StudyOctober 9, 2018Multi-Center Study Shows Improved, Stable Clinical Outcomes in 96% of Patients with Brain METsAugust 9, 2018NICO Launches Investigator Initiated Study Program to Increase Scientific Data Supporting Minimally Invasive NeurosurgeryJuly 17, 2018NICO Corp. Adds to Strong Intellectual Property Portfolio of 200+ with New Patent Issued Around Revolutionary BrainPath TechnologyJune 19, 2018Global Healthcare Senior Executive Joins NICO Corp. Board of DirectorsJune 6, 2018Accomplished CEO & Entrepreneur of the Year Joins NICO Corp. Board of DirectorsMay 31, 2018Early Intervention of Hemorrhagic Stroke Trial Reaches 100 PatientsMay 29, 2018Former Neurosurgery Chairman of Henry Ford Health System, Dr. Mark Rosenblum, Joins NICO Corporation Board of DirectorsMay 22, 2018New Published Evidence for Deadly High-Grade Gliomas Linked to Improved SurvivalMay 1, 2018NICO Continues to Innovate with Smallest Trans-Sulcal Brain Access Tool in the WorldJanuary 18, 2018NICO Corporation Appoints New Vice President of SalesOctober 10, 2017Inclusion of NICO BrainPath Approach for Minimal Access Surgery into Pilot ERAS Protocol Supports Possibility for Improved Patient OutcomesOctober 9, 2017Data on Largest Adult Patient Cohort Shows Diversity, Utility of NICO BrainPath® for Treatment of Tumors, Hemorrhages Located in Deep Subcortical RegionsAugust 28, 2017New Study Reveals Nearly $12,000 per Patient Economic Benefit for Hospitals Using New Technology for Brain Tumor Removal and Stroke TreatmentJuly 27, 2017High Interest in Early Removal of Hemorrhagic Stroke Leads to Doubling Number of Clinical Trial SitesApril 3, 2017NICO Announces CE Mark for BrainPath® Non-Disruptive Cranial Access TechnologyFebruary 22, 2017Top Academic Healthcare Centers Presenting New Surgical Options for Stroke PatientsJanuary 23, 2017FDA Grants New Clearance for Brain Surgery TechnologyFebruary 23, 2016Neurosurgery Device Maker Completes $15 Million Capital Raise to Address Increasing Market Demand of New Technologies for Tumor and StrokeJanuary 13, 2016NICO Announces Hemorrhagic Stroke Trial Lead by Emory University and Grady MemorialSeptember 28, 2015NICO Announces Collaboration with Hitachi Aloka Medical to Create Improved Visualization for Difficult to Reach Brain TumorsJuly 27, 2015NICO Receives Additional FDA Clearance for Specific BrainPath® Indications for Subcortical Access to Brain Tumors, Cysts and Vascular DiseaseMay 5, 2015NICO Corporation Gains Market Expansion after Multiple Published Clinical Articles Support Access Technology for Deep Brain LesionsFebruary 12, 2015Multi-Center Intracerebral Hemorrhage Pilot Study Yields Statistically Significant Data for Early InterventionSeptember 3, 2014NICO BrainPath® Medical Device for Safely Accessing the Brain Wins Indiana Innovation Award EventsJune 3, 2019Neurosurgery Medical Device Maker, NICO Corporation, Expands Globally with International Training Course During World Stroke Meeting in SpainApril 23, 2019New Evidence Shows Brain Recovery after Traumatic & Spontaneous Intracerebral Hemorrhage using NICO Minimally Invasive BrainPath ApproachNovember 19, 2018NICO Completes $12.5 Million Capital Raise Supported by Current ShareholdersNovember 14, 2018NICO Awards First Investigator Initiated Study Grant to Mayo ClinicNovember 14, 2018Viz.ai and NICO Announce Collaboration to Speed Patient Recruitment in the ENRICH StudyOctober 9, 2018Multi-Center Study Shows Improved, Stable Clinical Outcomes in 96% of Patients with Brain METsAugust 9, 2018NICO Launches Investigator Initiated Study Program to Increase Scientific Data Supporting Minimally Invasive NeurosurgeryJuly 17, 2018NICO Corp. Adds to Strong Intellectual Property Portfolio of 200+ with New Patent Issued Around Revolutionary BrainPath TechnologyJune 19, 2018Global Healthcare Senior Executive Joins NICO Corp. Board of DirectorsJune 6, 2018Accomplished CEO & Entrepreneur of the Year Joins NICO Corp. Board of DirectorsMay 31, 2018Early Intervention of Hemorrhagic Stroke Trial Reaches 100 PatientsMay 29, 2018Former Neurosurgery Chairman of Henry Ford Health System, Dr. Mark Rosenblum, Joins NICO Corporation Board of DirectorsMay 22, 2018New Published Evidence for Deadly High-Grade Gliomas Linked to Improved SurvivalMay 1, 2018NICO Continues to Innovate with Smallest Trans-Sulcal Brain Access Tool in the WorldJanuary 18, 2018NICO Corporation Appoints New Vice President of SalesOctober 10, 2017Inclusion of NICO BrainPath Approach for Minimal Access Surgery into Pilot ERAS Protocol Supports Possibility for Improved Patient OutcomesOctober 9, 2017Data on Largest Adult Patient Cohort Shows Diversity, Utility of NICO BrainPath® for Treatment of Tumors, Hemorrhages Located in Deep Subcortical RegionsAugust 28, 2017New Study Reveals Nearly $12,000 per Patient Economic Benefit for Hospitals Using New Technology for Brain Tumor Removal and Stroke TreatmentJuly 27, 2017High Interest in Early Removal of Hemorrhagic Stroke Leads to Doubling Number of Clinical Trial SitesApril 3, 2017NICO Announces CE Mark for BrainPath® Non-Disruptive Cranial Access TechnologyFebruary 22, 2017Top Academic Healthcare Centers Presenting New Surgical Options for Stroke PatientsJanuary 23, 2017FDA Grants New Clearance for Brain Surgery TechnologyFebruary 23, 2016Neurosurgery Device Maker Completes $15 Million Capital Raise to Address Increasing Market Demand of New Technologies for Tumor and StrokeJanuary 13, 2016NICO Announces Hemorrhagic Stroke Trial Lead by Emory University and Grady MemorialSeptember 28, 2015NICO Announces Collaboration with Hitachi Aloka Medical to Create Improved Visualization for Difficult to Reach Brain TumorsJuly 27, 2015NICO Receives Additional FDA Clearance for Specific BrainPath® Indications for Subcortical Access to Brain Tumors, Cysts and Vascular DiseaseMay 5, 2015NICO Corporation Gains Market Expansion after Multiple Published Clinical Articles Support Access Technology for Deep Brain LesionsFebruary 12, 2015Multi-Center Intracerebral Hemorrhage Pilot Study Yields Statistically Significant Data for Early InterventionSeptember 3, 2014NICO BrainPath® Medical Device for Safely Accessing the Brain Wins Indiana Innovation Award Media CoverageJune 3, 2019Neurosurgery Medical Device Maker, NICO Corporation, Expands Globally with International Training Course During World Stroke Meeting in SpainApril 23, 2019New Evidence Shows Brain Recovery after Traumatic & Spontaneous Intracerebral Hemorrhage using NICO Minimally Invasive BrainPath ApproachNovember 19, 2018NICO Completes $12.5 Million Capital Raise Supported by Current ShareholdersNovember 14, 2018NICO Awards First Investigator Initiated Study Grant to Mayo ClinicNovember 14, 2018Viz.ai and NICO Announce Collaboration to Speed Patient Recruitment in the ENRICH StudyOctober 9, 2018Multi-Center Study Shows Improved, Stable Clinical Outcomes in 96% of Patients with Brain METsAugust 9, 2018NICO Launches Investigator Initiated Study Program to Increase Scientific Data Supporting Minimally Invasive NeurosurgeryJuly 17, 2018NICO Corp. Adds to Strong Intellectual Property Portfolio of 200+ with New Patent Issued Around Revolutionary BrainPath TechnologyJune 19, 2018Global Healthcare Senior Executive Joins NICO Corp. Board of DirectorsJune 6, 2018Accomplished CEO & Entrepreneur of the Year Joins NICO Corp. Board of DirectorsMay 31, 2018Early Intervention of Hemorrhagic Stroke Trial Reaches 100 PatientsMay 29, 2018Former Neurosurgery Chairman of Henry Ford Health System, Dr. Mark Rosenblum, Joins NICO Corporation Board of DirectorsMay 22, 2018New Published Evidence for Deadly High-Grade Gliomas Linked to Improved SurvivalMay 1, 2018NICO Continues to Innovate with Smallest Trans-Sulcal Brain Access Tool in the WorldJanuary 18, 2018NICO Corporation Appoints New Vice President of SalesOctober 10, 2017Inclusion of NICO BrainPath Approach for Minimal Access Surgery into Pilot ERAS Protocol Supports Possibility for Improved Patient OutcomesOctober 9, 2017Data on Largest Adult Patient Cohort Shows Diversity, Utility of NICO BrainPath® for Treatment of Tumors, Hemorrhages Located in Deep Subcortical RegionsAugust 28, 2017New Study Reveals Nearly $12,000 per Patient Economic Benefit for Hospitals Using New Technology for Brain Tumor Removal and Stroke TreatmentJuly 27, 2017High Interest in Early Removal of Hemorrhagic Stroke Leads to Doubling Number of Clinical Trial SitesApril 3, 2017NICO Announces CE Mark for BrainPath® Non-Disruptive Cranial Access TechnologyFebruary 22, 2017Top Academic Healthcare Centers Presenting New Surgical Options for Stroke PatientsJanuary 23, 2017FDA Grants New Clearance for Brain Surgery TechnologyFebruary 23, 2016Neurosurgery Device Maker Completes $15 Million Capital Raise to Address Increasing Market Demand of New Technologies for Tumor and StrokeJanuary 13, 2016NICO Announces Hemorrhagic Stroke Trial Lead by Emory University and Grady MemorialSeptember 28, 2015NICO Announces Collaboration with Hitachi Aloka Medical to Create Improved Visualization for Difficult to Reach Brain TumorsJuly 27, 2015NICO Receives Additional FDA Clearance for Specific BrainPath® Indications for Subcortical Access to Brain Tumors, Cysts and Vascular DiseaseMay 5, 2015NICO Corporation Gains Market Expansion after Multiple Published Clinical Articles Support Access Technology for Deep Brain LesionsFebruary 12, 2015Multi-Center Intracerebral Hemorrhage Pilot Study Yields Statistically Significant Data for Early InterventionSeptember 3, 2014NICO BrainPath® Medical Device for Safely Accessing the Brain Wins Indiana Innovation Award
